News & Trends - Biotechnology

AusBiotech and academia partner on ‘gold standard’ approach to translation of medical research

Health Industry Hub | March 14, 2022 |
[Total: 1    Average: 4/5]

Biotech News: The development of an Australian-first gold standard framework to ensure health and medical discoveries are more accessible to industry and can be fast-tracked to commercialisation opportunities has been facilitated by the University of Sydney’s Faculty of Medicine and Health, Sydney Business School and AusBiotech.

The partnership focused on wide consultation with almost 100 industry leaders coupled with benchmarking international institutions that successfully co-located with researchers, start-ups and business incubators to deliver rapid innovation through the convergence of skills, perspectives and resources.

The result is 10 recommendations that reflect what industry and university partners would like to see for successful collaboration.

Professor Duncan Ivison, Deputy Vice-Chancellor (Research) at the University of Sydney, said “This helpful report reinforces the need for Australia to take a holistic and eco-system approach to research commercialisation – universities, industry, governments and consumers all have a crucial role to play in working collectively to get our best research out into the world making a positive difference.”

You may also like: Moderna partners locally to develop vaccines for emerging viruses

Professor Robyn Ward AM, Executive Dean and Pro Vice-Chancellor Medicine and Health at University of Sydney, added “Our vision is to establish a hub for the health and medical industry that transforms Australia’s research and commercialisation capabilities by developing a gold-standard in which the private sector and universities co-design and co-invest.

“Our universities are already contributing billions of dollars to the national economy and growing the health workforce, further collaboration between our leading researchers and prominent industry players will strengthen this and fast-track medical discoveries that could make a huge difference in people’s lives.”

The recommendations include strategies such as growing opportunities for proof-of-concept funding and career incentives, and secondments and training and development opportunities for academics and professional staff involved in commercialisation pathways. Up-skilling industry in academic processes, and publishing needs and streamlining the way commercialisation is negotiated and tracked are also discussed.

The recommendations will also be incorporated into AusBiotech’s ‘Biotechnology Blueprint: A Decadal Strategy for the Australian Biotechnology Industry’ as part of their decadal plan that builds both a thriving ecosystem and develops a sovereign capability for Australia.

AusBiotech’s CEO, Lorraine Chiroiu, said “The Biotechnology Blueprint has clearly articulated that creating strong and effective partnerships between the Australian biotechnology industry and universities will significantly contribute to commercialising high-quality ideas, and to creating a better connected and more vibrant community.

“This industry-academia collaboration framework is an important step towards that, as it identifies opportunities for the entire community – from bench to bedside – and aims to nurture an agile, nimble and interconnected environment that is able to consistently create and grow high-value biotech companies.”

Human Resources

Only 29% of employees say their leader shows ‘human leadership’

Health Industry Hub | June 24, 2022 |

Human Resources: A survey of more than 230 HR leaders revealed that 90% believe that to succeed in today’s work environment, […]


News & Trends - Medical Technology

MedTech News - Quantum HealthCare appointed as ANZ distributor for new medical technology

Quantum HealthCare appointed as ANZ distributor for new medical technology

Health Industry Hub | June 24, 2022 |

MedTech News: Alfred Health Hospital in Australia is set to receive first-in-nation portable MRI systems for point-of-care brain scans. US-based […]


News & Trends - Medical Technology

Medtech News - Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Health Industry Hub | June 24, 2022 |

MedTech News: The Australian Medical Association (AMA) is involved in proceedings before the Australian Competition Tribunal, opposing an attempt by […]


News & Trends - Medical Technology

Medtech News -

Medtronic award winner secures approval in diagnosis of gut disorders

Health Industry Hub | June 24, 2022 |

MedTech News: New Zealand based company and winner of the inaugural Medtronic APAC Innovation Challenge (MAIC) has received FDA approval […]


This content is copyright protected